Worldwide religious freedom legal organization Alliance Defending Freedom (ADF) filed a federal lawsuit Friday that challenges the Food and Drug Administration’s (FDA) approval of chemical abortion drugs mifepristone and misoprostol, claiming they present significant health risks to a pregnant woman as they also starve her unborn child to death.
“[T]he FDA failed America’s women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States,” the lawsuit, filed on behalf of the Alliance for Hippocratic Medicine, asserts. “And it has continued to fail them by repeatedly removing even the most basic precautionary requirements associated with their use.”
ADF states its lawsuit “is the culmination of decades-long efforts by ADF’s clients to hold the FDA accountable for its irresponsible actions.”
“The FDA approved chemical abortion drugs without basis and has spent decades removing what few protections were initially in place,” the legal organization adds.
According to ADF’s timeline, in May 1994, under pressure from the Clinton administration, French drug manufacturer Roussel Uclaf donated the U.S. patents rights to mifepristone, or RU-486, as it was called then, to John D. Rockefeller III’s Population Council, which sought to address what it viewed as world overpopulation.
ADF specifically noted the distorted narrative created by the FDA in order to manage approval of the abortion-inducing drugs:
The only way the FDA could have approved these pills was to characterize pregnancy as an “illness” and argue that these deadly drugs provide a “meaningful therapeutic benefit.” What’s more, in approving these pills, the FDA needed to disavow science because the FDA never studied the safety of the actual drug regimen, ignored the potential impacts of the hormone-blocking chemical on the developing bodies of adolescent girls, and disregarded the substantial evidence that chemical abortions cause more complications than even surgical abortions.
In May, the Charlotte Lozier Institute (CLI), the research arm of Susan B. Anthony Pro-Life America, revealed increased health risks for women who have been urged by abortion activists and providers to keep secret their drug-induced abortions if they require hospital admissions or surgeries for complications.
According to a CLI study, if a woman’s complications as a result of a drug-induced abortion are miscoded as a miscarriage in the ER, as advised by the abortion industry, she is more than twice as likely to need surgical admission and at significantly greater risk of multiple hospital admissions.
CLI reports the drug mifepristone works to “starv[e] the unborn baby of hormonal support.”
“When used as part of the abortion drug regimen, misoprostol induces contractions to expel the baby and placental tissue from the uterus,” the institute notes.
CLI also revealed in 2021 the dramatic spike in abortion pill-related emergency room visits.
Learn more: https://t.co/89nLYYtdlx
— Charlotte Lozier Institute (@LozierInstitute) May 26, 2022
“I’ve performed at least a dozen surgeries on women who experienced complications when the abortion pills failed,” said Ingrid Skop, M.D., F.A.C.O.G., CLI’s director of medical affairs. “I’ve cared for several women who took mifepristone and misoprostol and required blood transfusions or treatment for severe infections, and I’ve counseled women who experienced significant emotional distress after viewing the body of their easily identifiable child in the toilet.”
Skop noted as well:
Out here in Texas, away from the pro-abortion pundits and politicians, OB/GYNs are regularly called upon to address serious abortion pill complications that Planned Parenthood fails to treat and which the FDA doesn’t even bother to track. Right now, the abortion pill is promoted as safe under a “see no evil, hear no evil, report no data on evil” regime that puts the life and health of women and girls at risk.
“Alliance Defending Freedom files their lawsuit at a critical time, when the mainstream media and even the White House are willfully ignoring the known risks of abortion pills in pursuit of a pro-abortion political agenda,” she added.
James Studnicki, Sc.D., CLI’s vice president of data analytics and lead author of the abortion pill studies, asserted the abortion industry’s claims of the safety of chemical abortion is “greatly exaggerated”:
In fact, the increasing dominance of chemical abortion and its disproportionate contribution to emergency room morbidity is a serious public health threat, and the real-world data suggests that threat is growing.
“Our peer-reviewed research should alarm anyone who claims to be pro-woman, yet the current trend among pro-abortion politicians, bureaucrats, and their allies in the media is to turn a blind eye,” Studnicki said. “It shouldn’t take a lawsuit for the FDA to address a public health threat, but I’m grateful that Alliance Defending Freedom has taken this necessary action.”
Read the lawsuit:
– – –